113 related articles for article (PubMed ID: 8343276)
1. De novo cisplatinum resistance does not influence cellular radiosensitivity.
Britten RA; Warenius HM
Eur J Cancer; 1993; 29A(9):1315-20. PubMed ID: 8343276
[TBL] [Abstract][Full Text] [Related]
2. The differential induction of collateral resistance to 62.5 MeV (p-->Be+) neutrons and 4 MeV photons by exposure to cis-platinum.
Britten RA; Warenius HM; Masters JR; Peacock JH
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):837-43. PubMed ID: 8344853
[TBL] [Abstract][Full Text] [Related]
3. Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p-->Be+) neutrons than 4 MeV photons.
Warenius HM; Britten RA; Browning PG; Morton IE; Peacock JH
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):913-20. PubMed ID: 8138445
[TBL] [Abstract][Full Text] [Related]
4. Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumour cells.
Britten RA; Peacock J; Warenius HM
Radiother Oncol; 1992 Mar; 23(3):170-5. PubMed ID: 1574595
[TBL] [Abstract][Full Text] [Related]
5. The influence of hypoxia on the relative sensitivity of human tumor cells to 62.5 MeV (p-->Be) fast neutrons and 4 MeV photons.
Warenius HM; White R; Peacock JH; Hanson J; Britten RA; Murray D
Radiat Res; 2000 Jul; 154(1):54-63. PubMed ID: 10856966
[TBL] [Abstract][Full Text] [Related]
6. The inherent cellular sensitivity to 62.5 MeV(p----Be+) neutrons of human cells differing in photon sensitivity.
Britten RA; Warenius HM; Parkins C; Peacock JH
Int J Radiat Biol; 1992 Jun; 61(6):805-12. PubMed ID: 1351531
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of intrinsic cellular radiosensitivity following 4 MeV photons or 62.5 MeV (p-->Be+) neutrons. Potential implications for high LET therapy.
Warenius HM; Britten RA
Acta Oncol; 1994; 33(3):241-9. PubMed ID: 8018352
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the potential therapeutic gain of p(66)/Be neutrons and d(14)/Be neutrons.
Slabbert JP; Theron T; Zolzer F; Streffer C; Bohm L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1059-65. PubMed ID: 10863079
[TBL] [Abstract][Full Text] [Related]
9. The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p-->Be+) fast neutrons and 4 MeV photons.
Warenius HM; Britten RA; Peacock JH
Radiother Oncol; 1994 Jan; 30(1):83-9. PubMed ID: 8153385
[TBL] [Abstract][Full Text] [Related]
10. Influence of cisplatinum on intestinal tolerance to photon and neutron irradiation in mice.
Lambin P; Scalliet P; Coster B; M'Vondo JC; Vynckier S; Gueulette J; Wambersie A
Radiother Oncol; 1993 Jan; 26(1):73-5. PubMed ID: 8438090
[TBL] [Abstract][Full Text] [Related]
11. The merits of cell kinetic parameters for the assessment of intrinsic cellular radiosensitivity to photon and high linear energy transfer neutron irradiation.
Theron T; Slabbert J; Serafin A; Böhm L
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):423-8. PubMed ID: 9069317
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity variations in human tumor cell lines exposed in vitro to p(66)/Be neutrons or 60Co gamma-rays.
Slabbert JP; Theron T; Serafin A; Jones DT; Böhm L; Schmitt G
Strahlenther Onkol; 1996 Oct; 172(10):567-72. PubMed ID: 8899008
[TBL] [Abstract][Full Text] [Related]
13. Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin.
Twentyman PR; Wright KA; Rhodes T
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):217-20. PubMed ID: 1846846
[TBL] [Abstract][Full Text] [Related]
14. Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line.
Redpath JL; Hyden EC; Sun C
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):681-5. PubMed ID: 7790254
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines.
Yang X; Darling JL; McMillan TJ; Peacock JH; Steel GG
Radiother Oncol; 1990 Sep; 19(1):49-56. PubMed ID: 2122495
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitization of human tumor cells by ara-A to X irradiation and its relationship to inherent radioresponse.
Dahlberg WK; Little JB
Radiat Res; 1992 Jun; 130(3):303-8. PubMed ID: 1594756
[TBL] [Abstract][Full Text] [Related]
18. Micronucleus response of human glioblastoma and neuroblastoma cells toward low-LET photon and high-LET p(66)/Be neutron irradiation.
Akudugu JM; Slabbert JP; Roos WP; Böhm L
Am J Clin Oncol; 2003 Jun; 26(3):e1-6. PubMed ID: 12796609
[TBL] [Abstract][Full Text] [Related]
19. Inherent radiosensitivity and split-dose recovery in plateau-phase cultures of 10 human tumour cell lines.
Courdi A; Bensadoun RJ; Gioanni J; Caldani C
Radiother Oncol; 1992 Jun; 24(2):102-7. PubMed ID: 1496140
[TBL] [Abstract][Full Text] [Related]
20. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
Aldridge DR; Radford IR
Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
